Literature DB >> 20719552

Cysteinyl-leukotriene receptor antagonism blunts the acute hypotensive response to endotoxin in cats.

Amy E DeClue1, Claire R Sharp, Rachael L Cohen, Elizabeth F Leverenz, Carol R Reinero.   

Abstract

This study evaluated the effects of a cysteinyl-leukotriene-1 (cys-LT(1)) receptor antagonist, zarfirlukast, during feline endotoxemia. Six adult, sexually intact male cats received either placebo or zarfirlukast (10mg, PO) and endotoxin (2 μg/kg/h q 6h) in a cross-over design. Rectal temperature, heart rate, systolic arterial blood pressure, plasma tumor necrosis factor (TNF) activity, interleukin (IL)-6 concentration and urine cys-LT to creatinine ratio were evaluated. The rectal temperature, plasma TNF activity and IL-6 concentrations were significantly higher and systolic arterial blood pressure and heart rate significantly lower after endotoxin infusion. Cats treated with zafirlukast had a significantly higher blood pressure at 4h (P=0.002) compared to placebo. Urine cys-LT to creatinine ratio was significantly greater in the cats treated with zafirlukast compared to placebo (P=0.02). Zafirlukast administration ameliorated the acute hypotensive response to endotoxin in cats, but failed to significantly alter rectal temperature, heart rate or production of TNF and IL-6.
Copyright © 2010 ISFM and AAFP. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719552     DOI: 10.1016/j.jfms.2010.05.012

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  2 in total

Review 1.  The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.

Authors:  Malvina Hoxha; G Enrico Rovati; Aurora Bueno Cavanillas
Journal:  Eur J Clin Pharmacol       Date:  2017-04-04       Impact factor: 2.953

2.  Contrasting actions of diesel exhaust particles on the pulmonary and cardiovascular systems and the effects of thymoquinone.

Authors:  Abderrahim Nemmar; Suhail Al-Salam; Shaheen Zia; Fatima Marzouqi; Amna Al-Dhaheri; Deepa Subramaniyan; Subramanian Dhanasekaran; Javed Yasin; Badreldin H Ali; Elsadig E Kazzam
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.